Ledger.Open graph →
SEC Form D · filed July 31, 2012

Vedantra Pharmaceuticals, Inc

Offering
$5.0M
Sold
$3.3M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (5)

Alan Shaw · Cambridge, MAExec · Director · PromoterDaniel Behr · New York, NYDirectorAlan Shaw · Menlo Park, CAExec · Director · PromoterBen Bronstein · Cambridge, MADirectorDaniel Behr · Providence, RIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗